ENT Medical Device Patent Targets Chronic Sinusitis
An innovative team of medical device entrepreneurs operating out of Miami, FL, have successfully secured $1.5 million in funding for their patented Sinusleeve™ balloon that looks set to transform traditional Ear, Nose & Throat (ENT) procedures.
One of several patents was granted several years ago for the balloon sinus dilation sleeve that targets Chronic Sinusitis, a condition affecting over 30 million people in the United States alone.
The minimally-invasive ENT medical device is spearheaded by a serial entrepreneur and ENT MD, Dr. Agustin Arrieta who owns several other medical device patents. His partner is Peter Flores, a biotech engineer. They have set up an advisory board of 10 ENTs (and primary doctors) with astrong immediate focus on securing additional intellectual property (IP) and FDA approvals.
Additional funds will be used to produce inventory and accelerate sales and marketing efforts to support the rollout of the company’s first patented product, the Sinusleeve™ balloon.
This medical device offers a universal docking point for several existing ENT instruments. This will allow physicians to dilate the sinus ostia and spaces within the maxillary, frontal and sphenoid paranasal sinus cavities.
According to the company, The Sinusleeve™ Balloon provides a flexible alternative for dilating sinus ostia and spaces within the paranasal sinus cavities during Hybrid, FESS or standalone balloon dilation procedures.
Of particular interest to laymen, is the device’s ability to be used with both straight and curved ENT instruments, giving it a major advantage over rival inflation devices in marketplace. A key segment of the ENT Sinus Sleeve patent describes the restrictions physicians face when using traditional instrumentation and inflation devices:
“Other disadvantages with known inflation devices include the use of balloons or like expandable structures being used with only a specific positioning instrument, wherein the balloon or expandable structure may be integrated or connected directly to the specialized positioning instrument.” said the patent filing.
The inventors’ solution is to provide an improved dilator device which may be operatively positioned relative to an intended dilation site in a simple and efficient manner without requiring the use of specialized, integrated instrumentation.